Onset of phase correlations in YBa2Cu3O{7-x} as determined from reversible magnetization measurements

Isofield magnetization curves are obtained and analyzed for three single crystals of YBa2Cu3O{7-x}, ranging from optimally doped to very underdoped, as well as the BCS superconductor Nb, in the presence of magnetic fields applied both parallel and perpendicular to the $ab$ planes. Near Tc, the magnetization exhibits a temperature dependence \sqrt{M} [Ta(H)-T]^m. In accordance with recent theories, we associated Ta(H) with the onset of coherent phase fluctuations of the superconducting order parameter. For Nb and optimally doped YBaCuO, Ta(H) is essentially identical to the mean-field transition line Tc(H). The fitting exponent m=0.5 takes its mean-field value for Nb, and varies just slightly from 0.5 for optimally doped YBaCuO. However, underdoped YBCO samples exhibit anomalous behavior, with Ta(H)>Tc for H applied parallel to the c axis, suggesting that the magnetization is probing a region of temperatures above Tc where phase correlations persist. In this region, the fitting exponent falls in the range 0.5 < m < 0.8 for H\parallel c, compared with m~0. for $H\parallel ab planes. The results are interpreted in terms of an anisotropic pairing symmetry of the order parameter: d-wave along the ab planes and s-wave along the c axis.Comment: 5 pages, 4 figure

Effect of dietary omega-3 fatty acid deficiency on heart rate variability in hooded rats

Introduction: Recent reports in adult humans suggest that heart rate variability is modulated by the concentration of omega-3 polyunsaturated fatty acids (PUFA) contained in blood cell membranes. Material and methods: Hurst analysis of ECG data was conducted on 12 male adult hooded (Long-Evans) rats, representing the 3rd generation to be fed diets that were either deficient in, or supplemented with, omega-3 PUFA. ECG data were obtained from surface electrodes and 4000 beats were analyzed for each animal. Results: Dietary manipulation, despite leading to large changes in tissue omega- 3 PUFA levels, did not significantly affect the complexity of heart rate dynamics, with Hurst exponent (H) values of 0.15&plusmn;0.02 and 0.12&plusmn;0.03, for animals fed omega- 3 fatty acid-adequate and -deficient diets, respectively. Mean heart rate was also unaffected by the diets. A power calculation revealed that about one hundred animals per group would have been required to avoid a type II error. Conclusions: According to this model of dietary PUFA manipulation, omega-3 fatty acids are unlikely to exert a large effect on the autonomic functions that control heart rate variability. Prospective studies into the effect of omega-3 fatty acids on HRV should consider the need for large sample size as estimated by the results contained in this report.<br /

Global survey of the omega-3 fatty acids, docosahexaenoic acid and eicosapentaenoic acid in the blood stream of healthy adults

Published by Elsevier, and Made available in open-access under the CC-BY-4.0 International license http://creativecommons.org/licenses/by/4.0/. http:/dx.doi.org/10.1016/j.plipres.2016.05.001Studies reporting blood levels of the omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), were systematically identified in order to create a global map identifying countries and regions with different blood levels. Included studies were those of healthy adults, published in 1980 or later. A total of 298 studies met all inclusion criteria. Studies reported fatty acids in various blood fractions including plasma total lipids (33%), plasma phospholipid (32%), erythrocytes (32%) and whole blood (3.0%). Fatty acid data from each blood fraction were converted to relative weight percentages (wt.%) and then assigned to one of four discrete ranges (high, moderate, low, very low) corresponding to wt.% EPA + DHA in erythrocyte equivalents. Regions with high EPA + DHA blood levels (>8%) included the Sea of Japan, Scandinavia, and areas with indigenous populations or populations not fully adapted to Westernized food habits. Very low blood levels (<= 4%) were observed in North America, Central and South America, Europe, the Middle East, Southeast Asia, and Africa. The present review reveals considerable variability in blood levels of EPA + DHA and the very low to low range of blood EPA + DHA for most of the world may increase global risk for chronic disease. (C) 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license.DSM Nutritional Product

The average kinetic energy density of Cooper pairs above TcT_c in YBa2Cu3O7−x{\rm YBa_2Cu_3O_{7-x}}, Bi2Sr2CaCu2O8+δ{\rm Bi_2Sr_2CaCu_2O_{8+\delta}}, and Nb{\rm Nb}

We have obtained isofield curves for the square root of the average kinetic energy density of the superconducting state for three single crystals of underdoped $YBa_2Cu_3O_{7-x}$, an optimally doped single crystal of $Bi_2Sr_2CaCu_2O_{8+\delta}$, and Nb. These curves, determined from isofield magnetization versus temperature measurements and the virial theorem of superconductivity, probe the order parameter amplitude near the upper critical field. The striking differences between the Nb and the high-$T_c$ curves clearly indicate for the latter cases the presence of a unique superconducting condensate below and above $T_c$

It is time to talk about people: a human-centered healthcare system

Examining vulnerabilities within our current healthcare system we propose borrowing two tools from the fields of engineering and design: a) Reason's system approach [1] and b) User-centered design [2,3]. Both approaches are human-centered in that they consider common patterns of human behavior when analyzing systems to identify problems and generate solutions. This paper examines these two human-centered approaches in the context of healthcare. We argue that maintaining a human-centered orientation in clinical care, research, training, and governance is critical to the evolution of an effective and sustainable healthcare system

Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants.

ABSTRACT It is becoming clear that an adequate level of long-chain highly unsaturated fatty acids in the nervous system is required for optimal function and development; however, the ability of infants to biosynthesize long-chain fatty acids is unknown. This study explores the capacity of human infants to convert 18-carbon essential fatty acids to their elongated and desaturated forms, in vivo. A newly developed gas chromatography͞negative chemical ionization͞mass spectrometry method employing 2 H-labeled essential fatty acids allowed assessment of this in vivo conversion with very high sensitivity and selectivity. Our results demonstrate that human infants have the capacity to convert dietary essential fatty acids administered enterally as 2 H-labeled ethyl esters to their longer-chain derivatives, transport them to plasma, and incorporate them into membrane lipids. The in vivo conversion of linoleic acid (18:2n6) to arachidonic acid (20:4n6) is demonstrated in human beings. All elongases͞desaturases necessary for the conversion of linolenic acid (18:3n3) to docosahexaenoic acid (22:6n3) are also active in the first week after birth. Although the absolute amounts of n-3 fatty acid metabolites accumulated in plasma are greater than those of the n-6 family, estimates of the endogenous pools of 18:2n6 and 18:3n3 indicate that n-6 fatty acid conversion rates are greater than those of the n-3 family. While these data clearly demonstrate the capability of infants to biosynthesize 22:6n3, a lipid that is required for optimal neural development, the amounts produced in vivo from 18:3n3 may be inadequate to support the 22:6n3 level observed in breast-fed infants

α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans

Blood levels of polyunsaturated fatty acids (PUFA) are considered biomarkers of status. Alpha-linolenic acid, ALA, the plant omega-3, is the dietary precursor for the long-chain omega-3 PUFA eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA). Studies in normal healthy adults consuming western diets, which are rich in linoleic acid (LA), show that supplemental ALA raises EPA and DPA status in the blood and in breast milk. However, ALA or EPA dietary supplements have little effect on blood or breast milk DHA levels, whereas consumption of preformed DHA is effective in raising blood DHA levels. Addition of ALA to the diets of formula-fed infants does raise DHA, but no level of ALA tested raises DHA to levels achievable with preformed DHA at intakes similar to typical human milk DHA supply. The DHA status of infants and adults consuming preformed DHA in their diets is, on average, greater than that of people who do not consume DHA. With no other changes in diet, improvement of blood DHA status can be achieved with dietary supplements of preformed DHA, but not with supplementation of ALA, EPA, or other precursors.<br /